Finasteride Market Size & Share, by Product (1 mg, 5 mg); Application (Prostate Treatment, Hair Treatment); Distribution Channel (Online, Offline) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 2984
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Finasteride Market size was over USD 109.5 million in 2023 and is anticipated to reach USD 154.82 million by 2036, growing at around 2.7% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of finasteride is estimated at USD 111.87 million.

The growth of the market can be attributed to the increasing occurrence of baldness and hair loss among men, and growing supply of contaminated domestic water. Along with these, the rising prevalence of prostate cancer across the world and rapid increase in the geriatric population are also expected to drive market growth in the coming years. According to the American Cancer Society, in the year 2021, about 248,530 new cases of prostate cancer is estimated in the United States. Moreover, around 6 in 10 of the diagnosed cases belong to men who are 65 years or older.  Furthermore, growing number of research and development activities in the pharmaceutical industry, and escalating consumer spending on hair treatment products especially in emerging economies are projected to offer ample growth opportunities to the market in the near future.


Finasteride Market Graph
Get more information on this report: Request Free Sample PDF

Finasteride Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Occurrence of Hair Loss and Prostate Cancer
  • Growing R&D Activities in the Pharmaceutical Sector

Challenges

  • Side Effects of Using Finasteride
  • Rising Availability of Alternative Treatment Options

Finasteride Market: Key Insights

Base Year

2023

Forecast Year

2024–2036

CAGR

2.7%

Base Year Market Size (2023)

USD 109.5 million

Forecast Year Market Size (2036)

USD 154.82 million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Finasteride Segmentation

The market is segmented by application into prostate treatment, hair treatment and others, out of which, the segment for prostate treatment is anticipated to hold the largest share in the finasteride market on account of the rising cases of benign prostate hyperplasia (BPH). As per the Urology Care Foundation, about half of the men between the ages 51 and 60 years suffer from BPH. 90% of the men above the age of 80 years already have this disorder. High occurrence of the risk factors such as age, improper nutrition and genetic susceptibility are considered to be the underlying causes of the rapid spread of this condition since the last decade. The hair treatment segment is also predicted to observe notable growth over the forecast period owing to the growing incidence of alopecia among young adults and rise in emphasis on physical appearance. Additionally, on the basis of distribution channel, the online pharmacy segment in the market is assessed to witness the highest growth by the end of 2030. This can be credited to the consumer shift toward smart phones and digital technology, and increasing number of online medical stores over the last few years.

Our in-depth analysis of the global market includes the following segments:

           Product Type

  • 1 mg
  • 5 mg

             Application

  • Prostate Treatment
    • Prostate Cancer
    • Prostate Enlargement
    • Hormone Therapy
  • Hair Treatment
    • Scalp Hair Loss
    • Excessive Hair Growth
  • Others

           Distribution Channel

  • Online Pharmacy
  • Offline Pharmacy

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Finasteride Industry - Regional Synopsis

On the basis of geographical analysis, the finasteride market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The market in the Asia Pacific is set to hold largest revenue share by 2036, on the back of growing penetration of finasteride in developing and under-developing countries. In addition, rising number of hair product launches and increasing development of sales network of pharmaceutical companies is also anticipated to drive market growth in the region. Moreover, the market in North America is expected to acquire the largest market share during the forecast period ascribing to the high popularity of finasteride in the United States, increasing approval of generic and biosimilar drugs by the governments, and the strong presence of market players in the region. For instance, finasteride was the fourth most commonly prescribed medication in the US.

Research Nester
Finasteride-Market-Share-graph
Get more information on this report: Request Free Sample PDF

Companies Dominating the Finasteride Landscape

    • Novartis International AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Merck Sharp & Dohme Corp.
    • Teva Pharmaceuticals Limited
    • RelconChem Limited
    • Cipla Ltd.
    • Zhejiang CONBA Pharmaceutical
    • Actavis Pharmaceutical Company
    • Dr. Reddy's Laboratories
    • Henan Topfond Pharmaceutical Co., Ltd
    • Guangdong Eashu Pharmaceutical

In the News

· May 2021: The U.S. Federal Drug Administration (FDA) accepted the application for usage of tadalafil and finasteride as a combination capsule for the treatment of patients with benign prostatic hyperplasia (BPH).

Author Credits:  Radhika Pawar


  • Report ID: 2984
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of finasteride is estimated at USD 111.87 million.

Finasteride Market size was over USD 109.5 million in 2023 and is anticipated to reach USD 154.82 million by 2036, growing at around 2.7% CAGR during the forecast period i.e., between 2024-2036. The market growth is impelled by increasing occurrence of hair loss and prostate cancer and growing R&D activities in the pharmaceutical sector.

Asia Pacific is set to hold largest revenue share by 2036, on the back of growing penetration of finasteride in developing and under-developing countries.

The major players in the market are Novartis International AG, Merck Sharp & Dohme Corp., Teva Pharmaceuticals Limited, RelconChem Limited, Cipla Ltd., and others.

In the year 2024, the industry size of finasteride is estimated at USD 111.87 million.
Finasteride Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample